Sheets Smith Wealth Management

SEC CIK: 0001157436
Latest filing: Jul 13, 2026

SEC filings (opens in a new tab)

NBIX holding history

Neurocrine Biosciences Inc in every 13F filed by Sheets Smith Wealth Management, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NBIX overview All 13F holders of NBIX Full Q2 2026 holdings

Shares (Q3 2024): 0; Sold out in Q3 2024
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q4 2023

Holdings of NBIX by Sheets Smith Wealth Management, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2024	0	$0	0.0%	−2,159−100.0%	Sold out	Holders
Q2 2024	2,159	$297.2K	<0.1%	+101+4.9%	Added	Holders
Q1 2024	2,058	$283.8K	<0.1%	+9+0.4%	Added	Holders
Q4 2023	2,049	$270.0K	<0.1%	+2,049	New	Holders